Simmons Bank’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.01M | Sell |
125,117
-24,486
| -16% | -$641K | 0.17% | 123 |
|
|
2026
Q1 | $4.2M | Buy |
149,603
+1,517
| +1% | +$40.4K | 0.28% | 82 |
|
|
2025
Q4 | $3.69M | Sell |
148,086
-282
| -0.2% | -$7.11K | 0.25% | 95 |
|
|
2025
Q3 | $3.78M | Sell |
148,368
-6,025
| -4% | -$149K | 0.25% | 97 |
|
|
2025
Q2 | $3.74M | Sell |
154,393
-2,234
| -1% | -$52.1K | 0.27% | 94 |
|
|
2025
Q1 | $3.97M | Sell |
156,627
-5,523
| -3% | -$145K | 0.3% | 86 |
|
|
2024
Q4 | $4.3M | Sell |
162,150
-10,992
| -6% | -$298K | 0.31% | 81 |
|
|
2024
Q3 | $5.01M | Sell |
173,142
-7,051
| -4% | -$206K | 0.36% | 74 |
|
|
2024
Q2 | $5.04M | Sell |
180,193
-10,519
| -6% | -$290K | 0.38% | 67 |
|
|
2024
Q1 | $5.29M | Sell |
190,712
-86,768
| -31% | -$2.41M | 0.4% | 67 |
|
|
2023
Q4 | $7.99M | Buy |
277,480
+5,070
| +2% | +$153K | 0.65% | 40 |
|
|
2023
Q3 | $9.04M | Buy |
272,410
+1,260
| +0.5% | +$44.6K | 0.8% | 31 |
|
|
2023
Q2 | $9.95M | Buy |
271,150
+18,263
| +7% | +$711K | 0.84% | 26 |
|
|
2023
Q1 | $10.3M | Buy |
252,887
+6,426
| +3% | +$278K | 0.88% | 25 |
|
|
2022
Q4 | $12.6M | Buy |
246,461
+4,544
| +2% | +$218K | 1.09% | 17 |
|
|
2022
Q3 | $10.6M | Sell |
241,917
-3,939
| -2% | -$191K | 0.99% | 21 |
|
|
2022
Q2 | $12.9M | Buy |
245,856
+6,929
| +3% | +$353K | 1.13% | 15 |
|
|
2022
Q1 | $12.4M | Buy |
238,927
+1,218
| +0.5% | +$63.2K | 0.93% | 22 |
|
|
2021
Q4 | $14M | Sell |
237,709
-4,356
| -2% | -$216K | 0.98% | 17 |
|
|
2021
Q3 | $10.4M | Buy |
242,065
+5,656
| +2% | +$251K | 0.76% | 29 |
|
|
2021
Q2 | $9.26M | Buy |
236,409
+510
| +0.2% | +$19.8K | 0.67% | 34 |
|
|
2021
Q1 | $8.55M | Sell |
235,899
-12,588
| -5% | -$447K | 0.65% | 37 |
|
|
2020
Q4 | $9.15M | Sell |
248,487
-13,281
| -5% | -$487K | 0.73% | 33 |
|
|
2020
Q3 | $9.12M | Sell |
261,768
-5,091
| -2% | -$178K | 0.75% | 32 |
|
|
2020
Q2 | $8.28M | Buy |
266,859
+10,475
| +4% | +$356K | 0.68% | 37 |
|
|
2020
Q1 | $7.94M | Sell |
256,384
-224
| -0.1% | -$7.63K | 0.69% | 33 |
|
|
2019
Q4 | $9.54M | Sell |
256,608
-15,502
| -6% | -$552K | 0.86% | 26 |
|
|
2019
Q3 | $9.28M | Sell |
272,110
-2,721
| -1% | -$98.9K | 0.91% | 25 |
|
|
2019
Q2 | $11.3M | Buy |
274,831
+3,937
| +1% | +$156K | 1.09% | 19 |
|
|
2019
Q1 | $10.9M | Sell |
270,894
-1,026
| -0.4% | -$41.1K | 1.06% | 21 |
|
|
2018
Q4 | $11.3M | Sell |
271,920
-23,101
| -8% | -$959K | 1.26% | 17 |
|
|
2018
Q3 | $12.3M | Buy |
295,021
+15,423
| +6% | +$594K | 1.21% | 17 |
|
|
2018
Q2 | $9.62M | Sell |
279,598
-2,137
| -0.8% | -$73K | 0.87% | 19 |
|
|
2018
Q1 | $9.49M | Buy |
281,735
+34,196
| +14% | +$1.18M | 0.85% | 18 |
|
|
2017
Q4 | $8.51M | Sell |
247,539
-1,081
| -0.4% | -$36.9K | 0.86% | 22 |
|
|
2017
Q3 | $8.42M | Buy |
248,620
+32,503
| +15% | +$1.04M | 0.87% | 20 |
|
|
2017
Q2 | $6.89M | Buy |
216,117
+28,113
| +15% | +$887K | 0.77% | 24 |
|
|
2017
Q1 | $6.1M | Buy |
188,004
+3,303
| +2% | +$104K | 0.67% | 23 |
|
|
2016
Q4 | $5.69M | Buy |
184,701
+4,962
| +3% | +$151K | 0.64% | 28 |
|
|
2016
Q3 | $5.78M | Buy |
179,739
+963
| +0.5% | +$32.2K | 0.64% | 26 |
|
|
2016
Q2 | $5.97M | Buy |
178,776
+16,277
| +10% | +$519K | 0.66% | 26 |
|
|
2016
Q1 | $4.57M | Buy |
+162,499
| New | +$4.64M | 0.51% | 34 |
|
Other funds holding PFE
Simmons Bank's PFE Position: Q2 2026 in Review
Simmons Bank reduced its Pfizer (PFE) stake by 16% in Q2 2026, selling an estimated $641K and leaving 125,117 shares worth $3.01M. The position accounts for 0.17% of the portfolio, ranked #123.
Simmons Bank first reported a position in PFE in Q1 2016 and has held it in 42 quarters since. The position peaked at $14M in Q4 2021. 2,824 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Simmons Bank held 125,117 shares of Pfizer worth $3.01M as of Q2 2026.
- Simmons Bank sold 24,486 Pfizer shares in Q2 2026, an estimated $641K.
- Pfizer made up 0.17% of Simmons Bank's portfolio in Q2 2026, its #123 holding.
- Simmons Bank first reported a position in Pfizer in Q1 2016 and has held it in 42 quarters since.
- Simmons Bank's Pfizer position peaked at $14M in Q4 2021.
- 2,824 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Simmons Bank's 13F filing for Q2 2026, filed 31 Jul 2026.